SCHEMBL2522045

SCHEMBL2522045

C=C(C)C(=O)OCCC(N)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.53
TSHR P16473 4/20 0.52
ALDH1A1 P00352 2/20 0.41
TDP1 Q9NUW8 2/20 0.40
POLB P06746 1/20 0.39
APEX1 P27695 1/20 0.39
HTT P42858 1/20 0.39
CHRM5 P08912 3/20 0.33
CHRM1 P11229 3/20 0.33
CHRM3 P20309 3/20 0.33
CHRM2 P08172 2/20 0.33
CHRM4 P08173 2/20 0.33
EPHX1 P07099 1/20 0.32
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
ALOX15 P16050 1/20 0.31
MAPT P10636 1/20 0.30
BLM P54132 1/20 0.30
LMNA P02545 1/20 0.30
HTR1A P08908 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3988149 0.89 TSHR (0.60) THRBTSHRALDH1A1TDP1POLB
SCHEMBL6358410 0.88 TSHR (0.63) THRBTSHRALDH1A1TDP1POLB
SCHEMBL8608732 0.86 TSHR (0.67) THRBTSHRALDH1A1TDP1POLB
SCHEMBL23031388 0.84 THRB (0.52) THRBTSHRALDH1A1TDP1POLB
Urea SCHEMBL15263286 0.84 THRB (0.65) THRBTSHRALDH1A1TDP1POLB
SCHEMBL3818412 0.83 THRB (0.50) THRBTSHRALDH1A1TDP1POLB
SCHEMBL2453478 0.82 THRB (0.57) THRBTSHRALDH1A1TDP1POLB
SCHEMBL9312977 0.82 THRB (0.57) THRBTSHRALDH1A1TDP1POLB
SCHEMBL587661 0.82 THRB (0.57) THRBTSHRALDH1A1TDP1POLB
SCHEMBL10426403 0.82 THRB (0.57) THRBTSHRALDH1A1TDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150164853-A1 PROSTACYCLIN COMPOSITIONS FOR REGULATION OF FRACTURE REPAIR AND BONE FORMATION MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2015-06-18 US claimed
US-20110251677-A1 Coating Designs For The Tailored Release Of Dual Drugs From Polymeric Coatings ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) 2011-10-13 US claimed
WO-2009055306-A2 COATING DESIGNS FOR THE TAILORED RELEASE OF DUAL DRUGS FROM POLYMERIC COATINGS ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) 2009-04-30 WO claimed
US-20090104247-A1 Coating Designs For The Tailored Release Of Dual Drugs From Polymeric Coatings ABBOTT CARDIOVASCULAR SYSTEMS INC. 2009-04-23 US claimed
JP-6247917-A None JP disclosed
EP-3782599-B1 DENTAL POLYMERIZABLE COMPOSITION BASED ON CONDENSED SILANES VOCO GMBH (DE) 2025-09-17 EP disclosed
US-11992538-B2 Polymerizable dental composition based on condensed silanes VOCO GMBH (DE) 2024-05-28 US disclosed
CN-109666163-B Hybrid crosslinked dynamic polymer and application thereof 厦门逍扬运动科技有限公司 2023-05-12 CN disclosed
US-20210052469-A1 POLYMERIZABLE DENTAL COMPOSITION BASED ON CONDENSED SILANES VOCO GMBH (DE) 2021-02-25 US disclosed
US-20210052469-A1 POLYMERIZABLE DENTAL COMPOSITION BASED ON CONDENSED SILANES VOCO GMBH (DE) 2021-02-25 US disclosed
EP-3782599-A1 DENTAL POLYMERIZABLE COMPOSITION BASED ON CONDENSED SILANES VOCO GmbH (DE) 2021-02-24 EP disclosed
EP-3782599-A1 DENTAL POLYMERIZABLE COMPOSITION BASED ON CONDENSED SILANES VOCO GmbH (DE) 2021-02-24 EP disclosed
US-20080124450-A1 copolymerizing an amino acid mimetic monomer and hydrophobic acrylate monomers; amino acid mimetic monomers selected to mimic the side chain of the amino acids Asn or gln can be a (meth)acryloyl derivative of 2-hydroxyacetamide, 3-hydroxypropionamide, alaninamide, lactamide; biocompatible; coated stent ABBOTT LABORATORIES (US) 2008-05-29 US disclosed
US-20080125514-A1 Biocompatible polymers that include an amino acid mimetic monomer and one or more hydrophobic acrylate monomers, the amino acid mimetic monomers being selected to mimic the side chain of the amino acids asparagine or glutamine; mechanical strength, drug permeability ABBOTT LABORATORIES (US) 2008-05-29 US disclosed
US-20080125514-A1 Biocompatible polymers that include an amino acid mimetic monomer and one or more hydrophobic acrylate monomers, the amino acid mimetic monomers being selected to mimic the side chain of the amino acids asparagine or glutamine; mechanical strength, drug permeability ABBOTT LABORATORIES (US) 2008-05-29 US disclosed
US-20080124450-A1 copolymerizing an amino acid mimetic monomer and hydrophobic acrylate monomers; amino acid mimetic monomers selected to mimic the side chain of the amino acids Asn or gln can be a (meth)acryloyl derivative of 2-hydroxyacetamide, 3-hydroxypropionamide, alaninamide, lactamide; biocompatible; coated stent ABBOTT LABORATORIES (US) 2008-05-29 US disclosed
WO-2006041559-A1 ADHESION PROMOTING COMPOSITION AND METHOD BASF CORPORATION (US) 2006-04-20 WO disclosed
US-20060074163-A1 An adhesion promoting formulation includes a polymer, such as an acrylic copolymer, having acetoacetoxy functionality and adhesion-promoting functionality and a metal alkoxide, chelate, and/or alkoxide chelate; coating over a metal surface or coated surface; refinishing; automobiles BASF CORPORATION (US) 2006-04-06 US disclosed
JP-H06247917-A PRODUCTION OF N-SUBSTITUTED CARBAMOYLETHYL (METH) ACRYLATE NIPPON SHOKUBAI CO LTD 1994-09-06 JP disclosed
EP-0172427-A2 Process for production of vinyl chloride polymer Shin-Etsu Chemical Co., Ltd. (JP) 1986-02-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150164853-A1 PROSTACYCLIN COMPOSITIONS FOR REGULATION OF FRACTURE REPAIR AND BONE FORMATION PTGIR, PTGIS, PTGS1 THRB 1853/4885TSHR 3190/4885ALDH1A1 3437/4885
US-11992538-B2 Polymerizable dental composition based on condensed silanes NCAPH, RCC1, NCAPD2 THRB 4522/4885TSHR 4596/4885ALDH1A1 1481/4885
US-20210052469-A1 POLYMERIZABLE DENTAL COMPOSITION BASED ON CONDENSED SILANES NCAPH, RCC1, NCAPD2 THRB 4522/4885TSHR 4596/4885ALDH1A1 1481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.